Burkholderia cepacia–Induced IL-8 Gene Expression in an Alveolar Epithelial Cell Line: Signaling Through CD14 and Mitogen-Activated Protein Kinase
Authors:
- 1 September 2003
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 54 (3) , 297-305
Abstract
Burkholderia cepacia is a prevalent pulmonary pathogen in patients with cystic fibrosis (CF). The lung pathology observed in patients with CF is postulated to be due to an overexpression of chemokines. This study investigated the induction of the neutrophil chemoattractant chemokine IL-8 and the signaling pathways activated by B. cepacia–infected human lung epithelial A549 (HLE) cells. Cells were infected with B. cepacia (genomovar III of the B. cepacia complex), and reverse transcriptase–PCR and ELISA for the cytokines were performed. B. cepacia (multiplicity of infection ≥4:1) induced HLE cells to significantly secrete IL-8 in a more potent manner than the predominant CF pathogen Pseudomonas aeruginosa (multiplicity of infection ≥64:1). IL-8 secretion by B. cepacia–infected HLE cells was abrogated by the gene transcription inhibitor actinomycin D and the protein translation inhibitor cycloheximide, confirming that B. cepacia–induced IL-8 secretion was mediated through de novo protein synthesis. Treatment of B. cepacia with proteinase K failed to down-regulate IL-8 secretion; furthermore, IL-8 secretion by B. cepacia–infected HLE cells was abrogated by ≥80% in the presence of anti-CD14 [specific lipopolysaccharide (LPS) receptor] antibody, thus suggesting that the IL-8–inducing component of B. cepacia was LPS and therefore dependent on CD14. The p38 mitogen-activated protein kinase (MAPK) inhibitor and the extracellular signal-regulated kinase MAPK inhibitor significantly abrogated IL-8 secretion by B. cepacia–infected HLE cells (SB203580, ≥80% inhibition; PD98059, ≥30% inhibition). In conclusion, B. cepacia–induced IL-8 secretion in A549 airway epithelial cells is more potent than P. aeruginosa; is mediated through LPS, which is CD14 dependent; and involves activation of the p38 and ERK MAPK pathways.Keywords
This publication has 31 references indexed in Scilit:
- Invasion of human type II pneumocytes by Burkholderia cepaciaMicrobial Pathogenesis, 2001
- Invasion and Intracellular Survival of Burkholderia cepaciaInfection and Immunity, 2000
- Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophilsJournal of Clinical Investigation, 1999
- Burkholderia cepacia: medical, taxonomic and ecological issuesJournal of Medical Microbiology, 1996
- Inflammatory Cytokines in Cystic Fibrosis LungsAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Cystic fibrosisLung, 1994
- Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic FibrosisPediatric Research, 1993
- Plasma tumour necrosis factor alpha in cystic fibrosis.Thorax, 1991
- ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSISThe Lancet, 1985
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984